N/A N=65 Efficacy Study of Vaginal Mesh for Prolapse
Pelvic Organ Prolapse · Uterine Prolapse · Vaginal Prolapse
Primary: Number of Participants With Anatomic Cure at 3 Years — 20; 21; 8; 8 Participants — p=<0.05
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=181 A Personalized Health Behavior System
Social Isolation · Aging · Physical Activity
Primary: VO2 Max — 16.6; 16.8; 15.7; 18.5 mL/kg/min — p=.82
N/A N=232 Standardized Patient Encounters to Improve PrEP Counseling for Adolescent Girls and Young Women in Kenya
HIV/AIDS
Primary: Quality of PrEP Counseling Provided by Health Care Workers Delivering PrEP to Adolescent Girls and Young Women for HIV Prevention in Kenya — 73.6; 58.4; 57.2; 36.2…
Phase 4 N=110 Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
Breast Cancer
Primary: Clinically Significant Changes in Cardiac Function As Determined by Left Ventricular Ejection Fraction (LVEF) Measurements Using Echocardiography — 60.1; 62.1; -0.2…
N/A N=20 Validation of a Novel Foot Offloading Device
Plantar Fasciitis, Chronic · Heel Pain Syndrome · Fat Pad Syndrome
Primary: Change in Foot Pain From Screening/Baseline Visit to 4 Week Visit as Reported on the Pittsburgh Foot Survey. — 2.930 Score on a scale — p=0.0796
Phase 3 N=327 A Trial of AXS-05 in Patients With Major Depressive Disorder
Depression · Major Depressive Disorder
Primary: Change in MADRS Total Score From Baseline to Week 6 — 15.91; 12.04 score on a scale — p=0.002
N/A N=105 HepaSphere™ Microspheres Prospective Registry
Metastatic Colorectal Cancer
Primary: Overall Survival — 19 months
Phase 3 N=201 Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
Hepatitis B
Primary: Percent of Participants With Hepatitis B Surface Antigen (HBsAg) Loss by Week 240 — 4.1; 5.2 Percentage of participants — p=0.72
N/A N=21 Families With Substance Use and Psychosis: A Pilot Study
Psychosis · Substance Use · Substance Use Disorders
Primary: Percentage of Sessions Completed — 100 percentage of intervention sessions
N/A N=279 Improving Urinary Continence and Quality of Life in Prostate Cancer Patients
Urinary Incontinence
Primary: Amount of Urinary Leakage — 23.2; 22.3; 31.5; 11 grams
Phase 3 N=876 Open-Label Safety Study of AXS-05 in Subjects With Depression
Major Depressive Disorder · Treatment Resistant Depression · Depression
Primary: Incidence of Treatment-emergent AEs (TEAEs) Following Dosing With AXS-05 — 505 Participants
N/A N=346 The Grandmother Study: Grandmother Initiatives in Family Transformation
Women · Grandmother
Primary: Depressive Symptoms — 18.116; 18.231; 15.135; 15.873 score on a scale
N/A N=57 Establishing Novel Antiretroviral Imaging for Hair to Elucidate Non-Adherence (ENLIGHTEN)
Medication Adherence
Primary: Percent of Patient Participants That Received a MedViewer Report as Planned — 91.9 percentage of patient participants
Phase 3 N=30 Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study
Bone Density · Bone Loss · Anorexia Nervosa
Primary: Postero-anterior (PA) Lumbar Spine Bone Mineral Density by Dual-energy X-ray Absorptiometry (DXA) — 0.90; 0.87 g/cm^2 — p=0.009
N/A N=50 Caterpillar™ Arterial Embolization Device Post-Market Study
Embolization, Therapeutic
Primary: Technical Success — 55 Target Embolization Sites